沃华医药
(002107)
| 流通市值：41.77亿 | | | 总市值：42.19亿 |
| 流通股本：5.71亿 | | | 总股本：5.77亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 373,431,869.49 | 394,407,753.34 | 392,959,237.05 | 431,483,318.34 |
| 应收票据及应收账款 | 55,553,212.51 | 68,942,996.27 | 66,207,856.98 | 69,976,290.14 |
| 其中：应收票据 | 1,855,611.91 | 1,817,849.38 | 2,993,178.59 | 2,446,864.21 |
| 应收账款 | 53,697,600.6 | 67,125,146.89 | 63,214,678.39 | 67,529,425.93 |
| 应收款项融资 | 3,736,533.73 | 1,695,881.91 | 1,337,364.52 | 2,470,850.79 |
| 预付款项 | 3,869,430.62 | 2,353,770.45 | 3,164,811.6 | 2,983,407.61 |
| 其他应收款合计 | 2,884,490.82 | 1,321,316.88 | 2,173,249.71 | 1,683,658.87 |
| 存货 | 95,926,414.39 | 93,462,435.78 | 84,821,049.64 | 101,298,840.45 |
| 其他流动资产 | 4,077,285.61 | 4,586,782.04 | 4,599,161.85 | 4,760,440.04 |
| 流动资产合计 | 539,479,237.17 | 566,770,936.67 | 555,262,731.35 | 614,656,806.24 |
| 非流动资产: | | | | |
| 投资性房地产 | 16,751,996.31 | 16,932,684.66 | 17,113,373.01 | 17,294,061.36 |
| 固定资产 | 318,563,602.95 | 325,324,986.26 | 332,374,093.07 | 339,479,026.23 |
| 使用权资产 | 891,323.63 | 1,124,012.78 | 1,357,173.47 | 1,589,862.62 |
| 无形资产 | 34,048,807.16 | 34,339,715.21 | 34,639,170.61 | 34,938,625.66 |
| 商誉 | 32,508,664.53 | 32,508,664.53 | 32,508,664.53 | 32,508,664.53 |
| 递延所得税资产 | 348,443.28 | 355,467.09 | 418,249.48 | 377,525.82 |
| 其他非流动资产 | 47,884.88 | 13,500 | 20,690 | 10,000 |
| 非流动资产合计 | 403,160,722.74 | 410,599,030.53 | 418,431,414.17 | 426,197,766.22 |
| 资产总计 | 942,639,959.91 | 977,369,967.2 | 973,694,145.52 | 1,040,854,572.46 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 43,271,235.86 | 38,751,277.57 | 34,188,414.73 | 50,754,116.66 |
| 应付账款 | 43,271,235.86 | 38,751,277.57 | 34,188,414.73 | 50,754,116.66 |
| 预收款项 | 4,821.92 | 167,177.9 | - | - |
| 合同负债 | 3,406,875.33 | 5,276,684.48 | 2,608,388.98 | 2,421,581.92 |
| 应付职工薪酬 | 5,835,713.31 | 8,841,718.15 | 7,032,787.88 | 7,520,734.01 |
| 应交税费 | 17,677,125.5 | 13,311,512.7 | 17,453,183.57 | 12,568,613.01 |
| 其他应付款合计 | 39,000,362.96 | 37,545,758.63 | 38,518,317.65 | 40,613,301.04 |
| 一年内到期的非流动负债 | 1,062,646.97 | 920,311.6 | 911,849.87 | 903,388.13 |
| 其他流动负债 | 146,021,450.78 | 135,916,637.69 | 146,959,178.99 | 147,529,059.32 |
| 流动负债合计 | 256,280,232.63 | 240,731,078.72 | 247,672,121.67 | 262,310,794.09 |
| 非流动负债: | | | | |
| 租赁负债 | - | 233,380.88 | 513,331.6 | 789,715.59 |
| 长期应付职工薪酬 | 81,870.61 | 64,733.9 | 90,032.5 | 121,788.49 |
| 递延收益 | 11,033,338.04 | 11,737,747.01 | 12,766,836.02 | 13,499,465.83 |
| 递延所得税负债 | 3,694,147.81 | 3,702,932.64 | 3,932,184.98 | 3,940,969.81 |
| 非流动负债合计 | 14,809,356.46 | 15,738,794.43 | 17,302,385.1 | 18,351,939.72 |
| 负债合计 | 271,089,589.09 | 256,469,873.15 | 264,974,506.77 | 280,662,733.81 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 577,209,600 | 577,209,600 | 577,209,600 | 577,209,600 |
| 盈余公积 | 61,947,866.71 | 61,947,866.71 | 46,272,148.97 | 46,272,148.97 |
| 未分配利润 | 37,037,114.78 | 84,660,979.34 | 68,616,396.78 | 118,562,949.38 |
| 归属于母公司股东权益合计 | 676,194,581.49 | 723,818,446.05 | 692,098,145.75 | 742,044,698.35 |
| 少数股东权益 | -4,644,210.67 | -2,918,352 | 16,621,493 | 18,147,140.3 |
| 股东权益合计 | 671,550,370.82 | 720,900,094.05 | 708,719,638.75 | 760,191,838.65 |
| 负债和股东权益合计 | 942,639,959.91 | 977,369,967.2 | 973,694,145.52 | 1,040,854,572.46 |
| 公告日期 | 2026-04-08 | 2026-01-20 | 2025-10-18 | 2025-07-22 |
| 审计意见(境内) | | 标准无保留意见 | | |